Pharmaceuticals, Biotechnology and Life Sciences
OAKLAND, Calif.–(BUSINESS WIRE)–OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that TPX-100 treatment is associated with significant decreases in…
− Initial Results From ILLUMINATE-C Expected in Late 2020 – − In Phase 2 OLE, Lumasiran Treatment Resulted in 76…
– Results Demonstrate FPT155 was Well Tolerated in all Patients through Seven Cohorts, Allowing for Continuation of Dose Escalation and…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and…
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE…
BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative…
Appointment follows resignation of Director Dr. Charles Ryan STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or…
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Biochips Market (2019-2025)” report has been added to ResearchAndMarkets.com’s offering. The Asia-Pacific Biochips Market is expected to…
DUBLIN–(BUSINESS WIRE)–The “Kisqali- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. “Kisqali Drug Insight, 2019” highlights the drug…
DUBLIN–(BUSINESS WIRE)–The “Splendil- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. “Splendil Drug Insight, 2019” highlights the drug…